DarioHealth Corp. Deferred Costs, Noncurrent
DarioHealth Corp. (DRIO) had Deferred Costs, Noncurrent of $324.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredCosts · last filed 2026-08-11
- 2026-06-30: Deferred Costs, Noncurrent $324.00K.
- 2026-03-31: Deferred Costs, Noncurrent $251.00K.
- 2025-12-31: Deferred Costs, Noncurrent $176.00K.
- 2025-09-30: Deferred Costs, Noncurrent $160.00K.
| Period end | Deferred Costs, Noncurrent |
|---|---|
| 2026-06-30 | $324.00K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $251.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $176.00K 10-Q · filed 2026-08-11 |
| 2025-09-30 | $160.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $136.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $86.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $65.00K 10-K · filed 2026-03-19 |
| 2024-09-30 | $53.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $79.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $78.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $59.00K 10-K · filed 2025-03-10 |
| 2023-09-30 | $62.00K 10-Q · filed 2023-11-02 |
| 2023-06-30 | $76.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $79.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $41.00K 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |